Arnold, L.; Morak, M.; Kramer, N.; Berking, C.; Schefzyk, M.; Hassel, J.C.; Ziemer, M.; French, L.E.; Gutzmer, R.; Nashan, D.;
et al. Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors. Cancers 2025, 17, 1845.
https://doi.org/10.3390/cancers17111845
AMA Style
Arnold L, Morak M, Kramer N, Berking C, Schefzyk M, Hassel JC, Ziemer M, French LE, Gutzmer R, Nashan D,
et al. Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors. Cancers. 2025; 17(11):1845.
https://doi.org/10.3390/cancers17111845
Chicago/Turabian Style
Arnold, Lisa, Monika Morak, Nora Kramer, Carola Berking, Matthias Schefzyk, Jessica C. Hassel, Mirjana Ziemer, Lars E. French, Ralf Gutzmer, Dorothee Nashan,
and et al. 2025. "Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors" Cancers 17, no. 11: 1845.
https://doi.org/10.3390/cancers17111845
APA Style
Arnold, L., Morak, M., Kramer, N., Berking, C., Schefzyk, M., Hassel, J. C., Ziemer, M., French, L. E., Gutzmer, R., Nashan, D., & Heinzerling, L.
(2025). Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors. Cancers, 17(11), 1845.
https://doi.org/10.3390/cancers17111845
